Bone marrow stem cells co-transfected with transforming growth factor beta 3 and bone morphogenetic protein 2

doi:10.3969/j.issn.2095-4344.2013.27.018

Abstract

Abstract:

BACKGROUND: Bone morphogenetic protein 2 and transforming growth factor β are important factors in bone regeneration, increasing the expressions of bone morphogenetic protein 2 and transforming growth factor β can promote the osteogenic differentiation of bone marrow mesenchymal stem cells.
OBJECTIVE: To construct the lentivirus vector carrying bone morphogenetic protein 2 and transforming growth factor β3, and to observe the expression of lentivirus vector in bone marrow mesenchymal stem cells.
METHODS: The recombinant lentiviral vectors carrying transforming growth factor β3, bone morphogenetic protein 2 and green fluorescent protein were constructed with recombinant lentiviral technology, and then the recombinant lentiviral vectors were used to transfect the passage 3 rabbit bone marrow mesenchymal stem cells in vitro cultured (transfection group). The bone marrow mesenchymal stem cells transfected with single gene lentivirals (single gene transfection group) carrying transforming growth factor β3 and bone morphogenetic protein 2 or single lentivirals were as control (control group). At 1 week after trasfection, the total RNA and protein were extracted from each group for detection.
RESULTS AND CONCLUSION: The green fluorescence bone marrow mesenchymal stem cells transfected with transforming growth factor β3 and bone morphogenetic protein 2 gene for 3 days could be observed under fluorescence microscope, and the transfection efficiency was over 90%. Reverse transcription-PCR and Western blot results showed the mRNA and protein expressions of transforming growth factor β3 and bone morphogenetic protein 2 in the transfection group were higher than those in the single gene transfection group and the control group. The results indicate that lentivirus can successfully transfect transforming growth factor β3 and bone morphogenetic protein 2 into the bone marrow msenchymal stem cells and achieve its high expression, and these two genes have the synergistic effect of promoting expression.

Key words: stem cells, bone marrow-derived stem cells, transforming growth factor β3, bone morphogenetic protein 2, recombinant lentivirus, osteogenesis, bone marrow mesenchymal stem cells, transfection, provincial grants-supported paper, stem cell photographs-containing paper

CLC Number:

R394.2

Wang Ti-jun, Wang Chang-yao, Xia Chang-suo, Sui Ai-hua, Wang Ying-zhen. Bone marrow stem cells co-transfected with transforming growth factor beta 3 and bone morphogenetic protein 2[J]. Chinese Journal of Tissue Engineering Research, doi: 10.3969/j.issn.2095-4344.2013.27.018.

Figures/Tables 5

References

[1] Jung HS, Kwon BS, Lee SW. Tumor-specific gene delivery using RNA-targeting Tetrahymena group I intron. Biotechnol Lett. 2005;27(8):567-574.

[2] Wang Y, Zeng B, Li X. Expression of human calcitonin by microencapsulated recombinant myoblasts. Biotechnol Lett. 2006;28(18):1453-1458.

[3] Tseng SS, Lee MA, Reddi AH. Nonunions and the potential of stem cells in fracture-healing. J Bone Joint Surg Am. 2008;90 Suppl 1:92-98.

[4] Hay E, Hott M, Graulet AM, et al. Effects of bone morphogenetic protein-2 on human neonatal calvaria cell differentiation. J Cell Biochem. 1999;72(1):81-93.

[5] Noshi T, Yoshikawa T, Dohi Y, et al. Recombinant human bone morphogenetic protein-2 potentiates the in vivo osteogenic ability of marrow/hydroxyapatite composites. Artif Organs. 2001;25(3):201-208.

[6] Perrien DS, Young CS, Alvarez-Urena PP, et al. Percutaneous injection of Augment Injectable Bone Graft (rhPDGF-BB and β-tricalcium phosphate [β-TCP]/bovine Type I collagen matrix) increases vertebral bone mineral density in geriatric female baboons. Spine J. 2013;13(5):580-586.

[7] Laurencin CT, Attawia MA, Lu LQ, et al. Poly(lactide-co-glycolide)/hydroxyapatite delivery of BMP-2-producing cells: a regional gene therapy approach to bone regeneration. Biomaterials. 2001;22(11):1271-1277.

[8] Johnsen SA, Subramaniam M, Katagiri T, et al. Transcriptional regulation of Smad2 is required for enhancement of TGFbeta/Smad signaling by TGFbeta inducible early gene. J Cell Biochem. 2002;87(2):233-241.

[9] 李雪峰,王东,孙海钰.骨组织工程中骨髓基质细胞的研究进展[J].基层医学论坛,2007,11(1):73-75.

[10] 翁玄,朱勇军,张健,等.不同分离方法及培养条件对兔骨髓间充质干细胞生物活性的影响[J].中国组织工程研究与临床康复,2010, 14(10):1775-1779.

[11] Verbruggen G, Wang J, Wang L, et al. Analysis of chondrocyte functional markers and pericellular matrix components by flow cytometry. Methods Mol Med. 2004;100: 183-208.

[12] 庞永刚,崔彭城,陈文弦,等.人骨髓间质干细胞作为骨、软骨组织工程种子细胞的实验研究[J].细胞与分子免疫学杂志,2004, 20(3):306-309.

[13] Bianco P, Riminucci M, Gronthos S, et al. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells. 2001;19(3):180-192.

[14] Javazon EH, Beggs KJ, Flake AW. Mesenchymal stem cells: paradoxes of passaging. Exp Hematol. 2004;32(5):414-425.

[15] Swieszkowski W, Tuan BH, Kurzydlowski KJ, et al. Repair and regeneration of osteochondral defects in the articular joints. Biomol Eng. 2007;24(5):489-495.

[16] Yamaguchi A, Ishizuya T, Kintou N, et al. Effects of BMP-2, BMP-4, and BMP-6 on osteoblastic differentiation of bone marrow-derived stromal cell lines, ST2 and MC3T3-G2/PA6. Biochem Biophys Res Commun. 1996;220(2):366-371.

[17] Boden SD, Grob D, Damien C. Ne-Osteo bone growth factor for posterolateral lumbar spine fusion: results from a nonhuman primate study and a prospective human clinical pilot study. Spine (Phila Pa 1976). 2004;29(5):504-514.

[18] 张永刚,卢世璧,王继芳.骨引导与骨诱导[J].中华创伤杂志,1996, 12(6):332-333．

[19] Mundy GR. Regulation of bone formation by bone morphogenetic proteins and other growth factors. Clin Orthop Relat Res. 1996;(324):24-28.

[20] Lind M. Growth factor stimulation of bone healing. Effects on osteoblasts, osteomies, and implants fixation. Acta Orthop Scand Suppl. 1998;283:2-37.

[21] Jagadeesan J, Bayat A. Transforming growth factor beta (TGFbeta) and keloid disease. Int J Surg. 2007;5(4):278-285.

[22] Kobayashi T, Liu X, Wen FQ, et al. Smad3 mediates TGF-beta1-induced collagen gel contraction by human lung fibroblasts. Biochem Biophys Res Commun. 2006;339(1): 290-295.

[23] Sailer HF, Kolb E. Application of purified bone morphogenetic protein (BMP) in cranio-maxillo-facial surgery. BMP in compromised surgical reconstructions using titanium implants. J Craniomaxillofac Surg. 1994;22(1):2-11.

[24] Hsu WK, Sugiyama O, Park SH, et al. Lentiviral-mediated BMP-2 gene transfer enhances healing of segmental femoral defects in rats. Bone. 2007;40(4):931-938.

[25] Tsuda H, Wada T, Yamashita T, et al. Enhanced osteoinduction by mesenchymal stem cells transfected with a fiber-mutant adenoviral BMP2 gene. J Gene Med. 2005;7(10): 1322-1334.

[26] Lieberman JR, Ghivizzani SC, Evans CH. Gene transfer approaches to the healing of bone and cartilage. Mol Ther. 2002;6(2):141-147.

[27] McMahon JM, Conroy S, Lyons M, et al. Gene transfer into rat mesenchymal stem cells: a comparative study of viral and nonviral vectors. Stem Cells Dev. 2006;15(1):87-96.

[28] Naldini L, Blömer U, Gage FH, et al. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci U S A. 1996;93(21):11382-11388.